Professor Noel Whelan:

I thank the Chairman for giving us the opportunity to come before the committee today. I am joined by fellow board members and non-executive directors. They are: Mr. Stewart Harrington, deputy chairman of the group; Mr. James Menton, chair of the finance committee; Mr. Thomas Lynch, a non-executive director with extensive experience in the pharmaceutical industry; and Mr. Nicky Jermyn, executive director.